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ABSTRACT 
CRYPTIC SUBTELOMERIC REARRANGEMENTS AND STUDIES OF TELOMERE LENGTH 
Jasen Lee Wise 
Study One: An estimated five percent of individuals with unexplained mental retardation (MR) 
have chromosomally unbalanced subtelomere regions. Around half of these individuals inherited 
the imbalance from a parent with a balanced rearrangement.  The frequency of carriers for 
cryptic balanced translocations is unknown.  To determine this frequency, blood samples 
received from 565 out of 978 phenotypically normal, unrelated individuals were examined using 
fluorescent in situ hybridization (FISH) probes to analyze all subtelomere regions. No balanced 
subtelomeric rearrangements were identified. The frequency of balanced cryptic translocations in 
the general population was estimated to be 1/8,000 from the literature. However, three females 
out of 379 (0.8%) in this study were determined to be mosaic with regard to the X chromosome. 
This is a higher frequency than the 1 in 1000 (0.1%) reported incidence for sex chromosome 
aneuploidies.  Study Two: From a clinically abnormal population, 256 patients with unexplained 
MR and normal karyotypes were tested for subtelomere rearrangements using FISH probes.  
Nine were abnormal (3.5%), in which five were deletions and four were deletion/duplications. 
Two polymorphisms (0.7%) were observed. Parents for five of the abnormal cases were 
evaluated and all but one was inherited from a parent with a balanced subtelomeric translocation 
or the same deletion with a similar abnormal phenotype. Study Three: Most human telomere 
length studies have focused on the overall length of telomeres within a cell. Very few studies 
have examined telomere length for individual chromosome arms. The relationship between 
chromosome arm size and the relative length of the associated telomere was studied in cultured 
lymphocytes from 17 individuals using quantitative FISH (Q-FISH). A statistically significant 
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“Chromosome” is the title given to the organizational structures of DNA and associated 
proteins during metaphase when DNA is at the highest level of compaction.  The human genome 
is organized into 22 pairs of autosomes and 1 pair of sex chromosomes (X and Y), totaling 46 
chromosomes.  Chromosomes are visible during metaphase after DNA replication has occurred 
and before sister chromatids separate during anaphase.   
To form the chromosome structure, double stranded DNA is wrapped around a core of 8 
histone proteins, making up the nucleosome,  referred to as “beads on a string.” The nucleosome 
then forms the 30 nm fiber “solenoid” which is the configuration of chromatin in interphase.  
During mitosis, solenoids coil on themselves multiple times to form supercoils, which attach to 
scaffold proteins. This is the chromosome that is seen during metaphase, the period in which 
DNA has the highest level of compaction (Fig. 1).  A chromosome is composed of three distinct 
structural regions; the centromere, the telomere, and the subtelomere (Fig. 2). 
CENTROMERE FUNCTION 
Each chromosome has a constriction point called the centromere, which holds sister 
chromatids together after DNA synthesis and gives the chromosome its characteristic shape.  The 
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centromere also divides the chromosome into two sections, or “arms.” The short arm of the 
chromosome is labeled the “p arm.” The long arm of the chromosome is labeled the “q arm.”  
The centromere is also where kinetochore formation takes place: proteins bind on the 
centromeres that form an anchor point for the spindle fibers, which are required for pulling 
chromosomes toward the centrioles during anaphase of mitosis.  Improperly functioning 
centromeres result in chromosomes that do not align, attach and/or separate chromatids properly, 




Figure 1.  Organizational levels of the chromosome (A) Double stranded DNA (B) DNA organized around  histone proteins 
making the “beads on a string” or nucleosome structure. (C) 30 nm fiber solenoid (D) supercoiling, (E) supercoiling around 




Figure 2.  Basic structure of a chromosome (not to scale) showing the p (short) and q (long) arms of the chromosome, the 
centromere, subtelomere and telomere regions (Figure courtesy of Deb Lanzendorfer based on ISCN 2009). 
THE TELOMERE  
The telomere was discovered in 1938 by Muller.  After x-irradiating Drosophila 
chromosomes, he observed interstitial deletions and inversions, but did not see a rearrangement 
involving the terminal ends of the chromosomes. From these observations he proposed that the 
terminal ends of chromosomes were structurally different from interstitial regions and coined the 
term “telomere” from the Greek for “end” (telos) and “part” (meros) (Muller, 1938). 
In the 1940’s McClintock proposed that the telomere was a protective structure that 
prevented telomeric fusion.  In her studies with maize, she demonstrated that chromosomes 
without a telomere region formed dicentric chromosomes that resulted in loss, rearrangement, 
and other aberrations during subsequent cell division (McClintock, 1938, 1939, 1941).    
Telomeres “cap” the ends of chromosomes and prevent fusion with other chromosomes (De 
Lange, 2002; Saldanha et al., 2003). Chromosomes that are unprotected at their ends are 
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analogous to DNA with broken strands.  Without the telomere to protect the end of the 
chromosome, the chromosome would be prone to aberrations such as translocations and ring 
formations (Bailey et al., 1999; McEachern et al., 2000; Von Zglinicki et al., 2000). Thus, 
telomeres play a significant role in stabilizing the genome (Blackburn, 1991; Saldanha et al., 
2003; Graakjaer et al., 2004). 
THE STRUCTURE OF THE TELOMERE 
Human telomeres are dynamic nucleoprotein structures located at the terminal ends of 
chromosomes. They are composed of a noncoding, repetitive, G-rich hexanucleotide (TTAGGG) 
structure measuring 10-15 kilobases in length (Blackburn, 1984).  At the very distal end of the 
telomere is a 300 bp single-stranded segment which forms the T-loop. This loop is analogous to 
a 'knot' which stabilizes the telomere, preventing the chromosome from being recognized as 
breakpoints by the DNA repair machinery. Without the T-loop, chromosomal fusion would occur 
through joining of non-homologous ends. The T-loop is held together by seven known proteins 
collectively referred to as the shelterin complex (de Lange, 2005). 
Three shelterin subunits, TRF1, TRF2, and POT1 directly recognize TTAGGG repeats, 
which are interconnected by three additional shelterin proteins, TIN2, TPP1, and Rap1. Together 
they form a complex that allows cells to distinguish telomeres from sites of DNA damage. 
Without shelterin, telomeres are no longer hidden from the DNA damage surveillance and 
chromosome ends are inappropriately processed by DNA repair pathways (de Lange, 2005) 
leading to premature erosion of the telomere. There are several accessory proteins that associate 
with the shelterin complex, all of which are involved in protecting the telomere from being 
recognized as double strand breaks (Bailey and Goodwin, 2004; Szilard and Durocher, 2006; 
Van Overbeek and de Lange, 2006).  
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Lansdorp et al., (1996) had examined the telomere length of human chromosomes in cells 
from different tissues and found that sister chromatid telomere lengths were similar; however, 
the distribution of telomere lengths between chromosomes was not random.  Martens et al., 
(1998) found that there was a significant difference between the telomere length of individual 
chromosome arms, with a weak positive correlation between the length of chromosome arms and 
the corresponding telomeres. Graakjaer et al., (2003; 2006a; 2006b) had found that human 
telomere length correlated well with total length of the chromosome but did not have as strong a 
correlation with individual chromosome arm size. 
TELOMERE DYNAMICS IN THE CELL 
During each round of DNA replication, the telomere erodes due to two primary 
mechanisms. The first is a process known as the “end replication problem,” which was first 
proposed independently by James Watson and Alexei Olovnikov in the early 1970s (Olovnikov, 
1971; 1973; Watson, 1972). This problem is the result of the inability of DNA polymerase to 
begin DNA synthesis de novo and the 5’ to 3’ directionality of DNA synthesis. Therefore DNA 
synthesis cannot be completed on the lagging strand of DNA (Wang, 1991) (Fig. 3).  The second 
mechanism of telomere degradation is exposure to 5’ to 3’exonuclease digestion, which erodes 
DNA to produce 3’ overhangs.   
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Figure 3. The end replication problem. (A) DNA synthesis can occur without interruption in the 5’ to 3’ direction. B) 
DNA replication can only occur in the 5’ to 3’ direction so lagging strand replication leaves gaps shown in (C).  (D) 
The gaps are filled, but a small section at the end is not filled due to the lack of a 3’ OH group for DNA polymerase 
to bind. Thus the telomere shortens after each round of DNA replication (Figure courtesy of Deb Lanzendorfer).  
A cell normally divides a finite number of times (50 to 70) before an end point is reached 
and the cell undergoes senescence, followed by programmed cell death: this is referred to as the 
Hayflick limit (Hayflick and Moorhead, 1961). The first connection between telomere length and 
ageing was made by Cooke and Smith (1986). They noticed that the telomere repeat number in 
sex chromosomes from sperm were much longer than in adult cells.  They proposed that human 
gametes and stem cells circumvent telomere loss through telomerase activity. 
The erosion of telomeres may act as a “clock” to measure the number of cell divisions 
that have taken place (Harley et al., 1990; Allsopp et al., 1992; Kim et al., 1994).  In 2001, 
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Hemann and colleagues reported that the shortest telomere, not the average telomere length, 
determines cell viability and chromosome stability (Hemann et al., 2001). This may indicate that 
the shortest telomere on any chromosome arm in the cell may trigger cell senescence. 
In 1994, Slagboom et al. measured the size of terminal restriction fragments in genomic 
DNA from 123 monozygotic and dizygotic twins aged 2-95 years. They found the average rate 
of telomere erosion was 31 base pairs (bp) per year. Frenck et al., (1998) reported that the rate of 
telomere loss over time is the greatest during early childhood (1,000–3,000 bp/yr). The rate of 
telomere erosion then slows (30–60 bp/yr) as age increases. Rufer et al., (1999) confirmed these 
findings by demonstrating that telomere length decreases in lymphocytes as a function of age.   
TELOMERASE 
Telomerase was first discovered in Tetrahymena, a ciliated protozoan, by Blackburn in 
1984 (Blackburn, 1984).  Telomerase is a reverse transcriptase that carries its own RNA 
template.  It is composed of 2 subunits TERC and TERT.  The presence of the RNA template in 
telomerase allows for the extension of the telomere repeat.  Telomerase is inactive In normal 
somatic cells. Therefore, during normal somatic cell division there is an overall reduction in 
telomere length.  In rapidly reproducing cells such as germline and cancer cells, telomerase is 
active and the cell lines are immortalized (Chiu and Harley 1997; Dhaene et al., 1998; 2000; 
Lauzon et al., 2000). 
THE TELOMERE AND DISEASE 
Most cancer cells up regulate telomerase activity, thereby maintaining telomere length 
and maintaining cell proliferation. This does not mean that telomerase activity causes 
malignancy. Additional cell cycle checkpoints are involved in cell cycle regulation. Therefore, 
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malignancy occurs only when a combination of these check points are circumvented (Shay and 
Wright, 2001). However, telomerase activity is associated with >80% of malignancies (Bekaert 
et al., 2002; Saldanha et al., 2003; Shay and Wright, 2007), suggesting that tumor proliferation 
may be related to maintenance of telomere length.  
Short telomeres have been correlated to a multitude of diseases and environmental factors 
including diabetes (Allsopp et al., 1992; Demissie et al., 2006; Sampson et al., 2006), 
cardiovascular disease (Samani et al., 2001; Brouilette et al., 2003; 2007; Obana et al., 2003; 
Benetos et al., 2004; Fuster and Andres 2006; Kurz et al., 2006; Bekaert et al., 2007; Fitzpatrick 
et al., 2007), smoking (Satoh et al., 1996; Valdes et al., 2005; Morla et al., 2006), cognitive 
ageing (Harris et al., 2006; Martin-Ruiz et al., 2006), life stress (Epel et al., 2004; Lansdorp, 
2006), mood disorders (Simon et al., 2006), lack of exercise (Cherkas et al., 2008), mortality, 
(Martin-Ruiz et al., 2006) and obesity (Valdes et al., 2005; Zannolli et al., 2008).  Each of the 
previous factors all have a common connection in physiological stress which may lead to greater 
numbers of cell division.  It is important to note that although the correlations exist, short 
telomeres may not be the causative factor, but a result of the disease.  
SUBTELOMERE STRUCTURE  
Subtelomere regions on each chromosome arm are located between chromosome-specific 
sequences and the arrays of telomeric repeats that cap the chromosome. Subtelomeres are the 
most distal sequences of non-repetitive unique-sequence DNA on the chromosome, have the 
highest density of genes in the human genome and are prone to recombination (Helias-
Rodzewicz et al., 2002). Subtelomere regions consist of mosaic blocks of duplicated sequences 
with unique chromosome-specific sequences interspersed throughout.  This transition from the 
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terminal telomeric end to the specific sequences is gradual and on some chromosomes can be as 
large as 300 kb (Riethman et al., 2005).  
The composition of human subtelomeres is evident from fluorescent in situ hybridization 
(FISH) analyses of cloned segments of subtelomeric regions.  Some subtelomeres, such as 7q, 
have a simple structure and little homology to other ends. Other subtelomeres consist of 
duplicated genomic segments, or “duplicons”, that produce patterns of homology. For example, 
it has been shown that the human 3q subtelomere is related to at least 35 other chromosome ends 
(Brown, et al., 1990; Cross et al., 1990; de Lange, et al., 1990; Wilkie et al., 1991) 
Some subtelomeric sequences are repeated near centromeres and other interstitial 
locations. This indicates past transfers of material among these sites. For example, Ijdo et al. 
(1992) concluded that the presence of sequences at 2q13 is common to the ends of several 
chromosomes; two ancestral chromosomes fused end to end at this site to form human 
chromosome 2. 
Crossover frequency increases with distance from the centromere and degree of sequence 
homology. Due to the large amount of sequence homology and subterminal location, 
subtelomere regions are prone to recombination (Riethman et al., 2005). Rearrangements of the 
subtelomeres, resulting in deletions and/or duplications, have been shown to be a cause of mental 
retardation (MR) (Flint et al., 1995). 
CHROMOSOME ANALYSIS 
Human chromosomes have been studied since the early 1900s when the movement and 
behavior of the “dark staining bodies” from which chromosomes took their name was of great 
interest (Gartler, 2006).  In 1921, Theophilus S. Painter published his first paper on human 
chromosomes, showing the presence of a Y chromosome in male testicular preparations with a 
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total count of 48 chromosomes (Painter, 1921).  In 1956, Joe Hin Tjio and Albert Levan reported 
that the correct number of human chromosomes was 46. Their finding was due to advancements 
in cell culture techniques such as treatment with hypotonic solution which allowed better 
spreading of metaphase preparations (Tijo and Levan, 1956).  
The most common preparation of human chromosomes for constitutional analysis uses 
lymphocytes from peripheral blood.  The cells are cultured in nutrient-rich media with 
phytohemagglutinin (which stimulates cell division) for 3 days and are harvested using colcemid, 
which prevents the formation of spindle fibers and arrests the cell at metaphase when 
chromosomes are condensed and visible.  To promote a good view of the chromosomes, the cells 
are treated with a hypotonic solution which forces the cells to swell.  The cells are then fixed 
with an acidic acid/methanol solution which preserves the preparation. Cells are dropped onto 
slides, rupturing cells and allowing spreading of chromosomes to minimize overlapping. The 
chromosomes are then stained for visibility with Giemsa. 
Human chromosome analysis by karyotyping began in the early 1960s.  An image of a 
metaphase spread was taken and the chromosomes were cut from a photograph and arranged by 
size and position of the centromere. Currently, this is done digitally on a computer rather than by 
photographic methods.  
Giemsa-banding or G-banding is obtained by staining with Giemsa following digestion of 
proteins associated with chromosomes using trypsin.  This process yields a series of light and 
dark stained bands. The heterochromatic dark regions are late-DNA replicating and AT rich 
while the euchromatic light regions are early-DNA replicating and GC rich. Cells that have 450 
or more bands in a normal human haploid genome are used for karyotypic analysis (Fig. 4). 
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Figure 4. A normal G-banded karyotype at 550 band length. Chromosomes are arranged by size and centromere 
position. The sex chromosomes are arranged in the lower right hand corner (Figure courtesy of Dr. Sharon Wenger.) 
An international committee has met once every 5 to 10 years (since 1975) to standardize 
the nomenclature for human cytogenetic karyotyping.  The nomenclature is updated in a 
publication entitled the International System for Human Cytogenetic Nomenclature (ISCN), 
most recently published in 2009 (“International Standing Committee on Cytogenetic 
Nomenclature”, 2009). 
Currently, the karyotype is written in a standard format using the following order: 
Number of chromosomes, sex chromosome composition, numerical and structural abnormalities 
in numerical order, with breakpoints in parentheses.  The band numbers have been standardized 
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beginning at the centromere and increasing as the bands progress towards the terminal ends of 
the chromosome.  For example, the nomenclature 16q22.1 indicates the long arm of chromosome 
16 at band 22.1 (Fig. 5). A few examples of the nomenclature relevant to the studies within this 
work are located in Table 1. 
 
Figure 5. Chromosome 16 banding ideogram. In a karyogram the p arm is the shorter arm and oriented to the top. 
The numbers indicate a banding “landmark.”(Figure based on ISCN 2009 and is courtesy of Deb Lanzendorfer.) 
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Table 1. Examples of ISCN cytogenetic nomenclature 
Karyotype Interpretation 
46,XY A normal male karyotype 
46,XX A normal female karyotype 
47,XX,+21 
An abnormal female karyotype with an additional 
chromosome 21 
47,XY,+18 
An abnormal male karyotype with an additional chromosome 
18 
45,X An abnormal female karyotype with only 1 X chromosome 
47,XYY 
An abnormal male karyotype with an additional Y 
chromosome 
47,XXX[89]/46,XX[11] 
A mosaic female karyotype, the cell lines are separated by a / 
and percentages are located within brackets 
46,XX,del(5)(p15.3) 
A female karyotype with a terminal deletion located on the p 
arm of chromosome 5 at band 15.3 
46,XY,der(4)t(4;8)(p16;p23) 
A male karyotype with a derivative chromosome composed 
of a terminal deletion of chromosome 4p at band 16 and a 
duplication of chromosome 8 at band p23 to the telomere 
NUMERICAL CHROMOSOME ABNORMALITIES 
Chromosome abnormalities can be numerical, with extra or missing chromosomes as a 
result of nondisjunction or anaphase lag. Numerical abnormalities usually arise during meiosis 
and gamete formation.  In 1959, the earliest reports identified numerical chromosome 
abnormalities for autosomes in Down syndrome or trisomy 21 (Lejeune et al., 1959), and sex 
chromosomes including Turner syndrome or monosomy X (Ford et al., 1959), Klinefelter 
syndrome or 47,XXY (Jacobs and Strong, 1959), XXX females (Jacobs et al., 1959) and XYY 
males (Sandburg et al., 1961). The development of amniocentesis as an important clinical 
15 
application in the 1960s permitted the further development of the cytogenetics field for prenatal 
diagnosis (Steele and Breg, 1966) 
Nondisjunction or anaphase lag occurring during mitosis will give rise to an individual 
who is mosaic for both normal and abnormal cells.  If this aneuploidy occurs early during fetal 
development, higher percentages of mosaicism may occur.  Low percentages will be present if 
the error occurs at a later time during fetal development or after birth. In addition, mosaicism  
may be limited to an area of the body or a specific tissue. 
STRUCTURAL CHROMOSOME ABNORMALITIES 
Structural chromosome abnormalities include isochromosomes, translocations, 
inversions, deletions, or duplications.  Structural abnormalities often arise from crossing-over 
errors during recombination of homologous or non-homologous chromosomes.  Structural 
chromosomal abnormalities are balanced if there is no net gain or loss of chromosomal material, 
and unbalanced if there is net gain and/or loss. In general, balanced rearrangements (inversions, 
reciprocal translocations) have no effect on the phenotype.  There are exceptions to this, 
however, such as when a break during the formation of the inversion or balanced translocation 
disrupts a gene.  
A carrier of a balanced reciprocal translocation can produce gametes that after 
fertilization give rise to an entirely normal child, a phenotypically normal balanced carrier, or 
various unbalanced karyotypes with a combination of monosomy for part of one of the 
chromosomes and trisomy for part of the other. 
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FLUORESCENT IN SITU HYBRIDIZATION (FISH) 
A G-banded karyotype can readily detect deletions or duplications that are 5 megabases 
(Mb) or larger in size.  However, any duplication or deletion smaller than 5 Mb may be 
undetectable due to the resolution limits of the light microscope (Shaw-Smith et al., 2004). 
Molecular techniques have been developed to address the resolution limits of the G-
banded karyotype.  Fluorescent in situ hybridization (FISH) has provided a means to visually 
detect microdeletions and duplications in an interphase cell or a metaphase spread. First, a probe 
is constructed that is large enough to hybridize specifically with its target but not so large as to 
impede the hybridization process. The DNA probe is directly labeled with a fluorophore. 
Tagging can be done in various ways, such as nick translation or Polymerase Chain Reaction 
(PCR) using nucleotides labeled with a fluorophore (Pinkel et al., 1986). 
The hybridization is accomplished by layering a DNA probe onto a slide containing the 
fixed cells of interest. The probe and the nuclear DNA are codenatured by heat and then allowed 
to reanneal, such that specific binding will occur between homologous regions (Fig. 6).  
Repetitive DNA sequences must be blocked by adding short fragments of DNA to the sample.  
Excess probe is removed and the presence or absence of the probe target can be visualized with a 
fluorescent microscope and quantified on a cell by cell basis.  FISH probes can identify 
chromosome aberrations at a much higher resolution (<5 Mb) than classical cytogenetics, 
regardless of the stage of cell cycle. The resolution of a FISH probe is determined by its design, 




Figure 6. FISH. (A) Double stranded DNA (B) Cellular DNA is denatured into single strands by heat (C) A probe 
tagged with fluorochrome hybridized to complementary sequences of the DNA strand. (D) Metaphase chromosome 
where sister chromatids each contain a signal (E) During interphase two signals are observed representing a binding 
site on each chromosome. (Image courtesy of Deb Lanzendorfer.) 
 
Using ISCN nomenclature for FISH performed on a karyotyped metaphase spread, the 
total number of chromosomes and sex chromosomes is followed by “.ish” and a description of 
the FISH findings (Table 2). For interphase cell analysis, the karyotype is written starting with 
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nuc ish, followed by the probe locus used in parenthesis with “x #”, with # indicating the number 
of signals seen. For a deletion, the probe locus is followed by “-“. 
Table 2. Examples of ISCN FISH nomenclature 
46,XY.ish del(4)(4q35) 
(D4S2930-)mat 
A normal male karyotype, however FISH reveals a 




A normal male karyotype, however FISH reveals a derivative 
chromosome 9 composed of a deletion of the probe region on 
chromosome 9 and a copy number gain of the probe region of 
chromosome 10.  This was paternally inherited. 
46,XY.ish 22q11.2(D22S75x2) 
A normal male karyotype was obtained. Additionally, a 
fluorescent in situ hybridization (FISH) probe for 22q11.2 
was demonstrates 2 copy numbers of the D22S75 locus  
nuc ish(DXZ1x3) 
FISH was performed on interphase cells. Three signals for 
the centromere of the X chromosome were seen.  
nuc ish(D21Z1x3)[100/400]/ 
(D21Z1x2)[300/400] 
FISH was performed on interphase cells.  100 cells out of 
400 had 3 signals for the centromere of chromosome 21. 
 
Microdeletions are responsible for many identifiable syndromes including Wolf-
Hirschhorn (4p16.3), Williams (7q11.23), Prader-Willi (15q11.2 paternal), Angelman (15q11.2 
maternal),  and DiGeorge (22q11.2) syndromes. However, the deletion is not always detected on 
a G-banded karyotype.  In 1967, McGavin et al., described a case of Cri-du-chat (5p15.3) 
syndrome with an apparently normal karyotype (McGavin et al., 1967). Later in 1969, Hoehn 
and Engel suggested that minute deletions may be responsible for these patients’ syndromes 
(Hoehn and Engel, 1969).  
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In 1989, a family with multiple children affected with Cri-du-chat syndrome did not show 
a deletion on chromosome 5p by a G-banded karyotype. Restriction fragment length 
polymorphism (RFLP) analysis of the affected individuals showed monosomy of 5p15.1-pter 
region. It was then discovered by FISH that one of the parents was a balanced translocation 
carrier (Overhauser et al., 1989).  
In 1991, Altherr et al. reported a similar case involving a patient with Wolf-Hirschhorn 
syndrome. All initial karyotypes were reported as normal, but because the patient’s phenotype 
was that of Wolf-Hirschhorn syndrome, RFLP and FISH analyses were performed. The 
molecular testing identified a 4p terminal deletion that was inherited from a parent with a 
balanced cryptic translocation (Altherr et al., 1991). Since well characterized clinical 
presentations were found to be the result of cryptic imbalances inherited from a parent, it was 
hypothesized that other less-defined or uncharacterized phenotypes may be the result of cryptic 
rearrangements (Altherr et al., 1991).  
It was suggested by Ledbetter in 1992, that cryptic chromosome abnormalities could 
clinically be screened by FISH.  He further suggested that cryptic telomere imbalances may 
occur in children with unexplained MR, and that multicolor FISH probes could be used as an 
effective diagnostic tool (Ledbetter, 1992).  
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CHAPTER TWO 
BALANCED CRYPTIC SUBTELOMERIC REARRANGEMENTS AND 
X CHROMOSOME MOSAICISM: A STUDY OF 565 APPARENTLY 
NORMAL INDIVIDUALS WITH FLUORESCENT IN SITU 
HYBRIDIZATION 
INTRODUCTION 
The classification of mental retardation (MR) is typically divided into four categories: 
mild (IQ of 50-70), moderate (IQ of 35-50), severe (IQ of 20-35) and profound (IQ of less than 
20). Mild MR is ten times more frequent than the moderate, severe, and profound categories 
combined (Anderlid et al., 2002).  The incidence of MR in the general population has been 
estimated to be in the range of 1% to 3% (Baker et al., 2002; Harada et al., 2004; Shaffer, 2005; 
Palomares et al., 2006).  About 10 percent of all MR is the result of chromosome abnormalities 
(Flint and Wilkie, 1996).  An estimated 40% of severe MR and 10% of mild MR is the result of 
detectable chromosome abnormalities (Van Karnebeek et al., 2002).  The cause of MR can only 
be identified in 50% of affected individuals.  However, in cases of mild to moderate MR the 
cause is diagnosed in only 25% of these individuals. 
Unbalanced cryptic rearrangements of the subtelomere regions have been shown to be a 
cause of idiopathic MR (IMR). In 1995, Flint et al. was the first to report subtelomeric 
chromosomal rearrangements associated with mental retardation with unknown etiology. By 
using variable nucleotide tandem repeat (VNTR) polymorphism analysis, the researchers were 
able to show that 6% of individuals with idiopathic MR in their study had small subtelomeric 
abnormalities (Flint et al., 1995). 
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The first study using subtelomere FISH probes was reported in 1999, when Knight and 
colleagues screened 284 children with unexplained moderate to severe retardation and 182 
children with unexplained mild retardation. Their data showed that small (undetectable by 
karyotype) chromosomal abnormalities occurred with a frequency of 7.4% in the children with 
moderate to severe mental retardation, and of 0.5% in the children with mild retardation.  They 
estimated that the population incidence of these unbalanced rearrangements to be as high as 2.1 
in 10,000. Therefore, the researchers suggested that standard medical practice for individuals 
with unexplained MR and a normal G-banded karyotype should include testing for subtelomeric 
rearrangements using DNA FISH probes (Knight et al., 1999). 
In 2002, van Karnebeek et al., screened 184 children (under the age of 18) with an IQ of 
less than 85 for subtelomeric rearrangements by using FISH. Only one subtelomeric deletion 
(0.5%) was detected by FISH (de novo deletion 12q24.33-qter).  The authors concluded that this 
low frequency was likely explained by the lack of clinical selection bias for individuals who 
were at higher risk for such rearrangements. 
In 2004, Bocian et al. examined 84 families with history of IMR and normal G-banded 
karyotypes.  They identified nine (10.7%) subtelomeric rearrangements, of which six were of 
parental origin.   However, when retrospectively examined it was determined that most of the 
rearrangements could have been detected or suspected with high resolution G-banding with 
resolutions as low as the 550 band level.   
In 2005, Adeyinka et al. retrospectively examined 2,170 clinical records of individuals 
with MR, a normal G-banded karyotype, and subtelomere FISH results. One hundred thirty nine, 
(5.6%), had abnormalities of the subtelomere region.  Seventy-one patients had deletions, 53 had 
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derivative chromosomes, and 15 had balanced rearrangements. The abnormality was inherited in 
51.8% of patients. (Adeyinka et al., 2005).  
The largest study of subtelomeric rearrangements to date was a retrospective study with 
broad selection criteria including MR, developmental delay (DD), behavioral disorders, autism, 
and growth delay.  Of the 11,688 patients who had a normal karyotype, 357 (2.5%) were found 
to have subtelomeric rearrangements by FISH. The most common abnormalities reported in this 
study were deletions of 1p, 22q, 4p, 9q, 8p, 2q and 20p in that order. (Ravnan et al., 2006). 
In summary, the incidence of subtelomere abnormalities varies greatly, and depends on 
the stringency of the criteria involved in patient selection and sample size (Ravnan et al., 2006). 
For example, numerous studies have shown subtelomeric defects to be found in the range of 0.5-
10.7% of individuals with IMR and a normal karyotype (Knight et al., 1997, 1999; Anderlid et 
al., 2002; Bocian et al., 2004; Li and Zhao, 2004). Higher percentages (20%) were from studies 
using highly selective criteria, where selection of individuals was limited to those who had a 
phenotype suggestive of a chromosome disorder such as a family history of MR, growth 




Cytogenetically visible balanced translocations have an incidence of 1 in 600 in the 
general population (Estop et al., 1997). Parents who are carriers of balanced translocations with a 
normal phenotype can have children with unbalanced chromosomes.  Like visible 
rearrangements, cryptic balanced rearrangements (undetectable by a G-banded karyotype) can 
also result in children with an unbalanced rearrangement. Several studies have reported that half 
of all patients with an unbalanced cryptic rearrangement have inherited it from a parent with a 
cryptic balanced translocation, however the frequency of individuals who carry a balanced 
cryptic translocation is unknown. In this study, a population of 565 unrelated, phenotypically 
normal individuals was screened with subtelomere FISH probes to determine the incidence of 
balanced cryptic translocation carriers. 
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MATERIALS AND METHODS 
SAMPLE COLLECTION 
 Subjects for this study were from the Center for Oral Health Research in Appalachia 
(COHRA) (Polk et al., 2008), as an ongoing cross-sectional oral health etiology study.  COHRA 
enrolls families from two central West Virginia counties and two western Pennsylvania counties 
and performs a detailed assessment protocol after an informed consent process approved by the 
Institutional Review Boards (IRB) of the University of Pittsburgh and West Virginia University 
(WVU).  A total of 978 COHRA subjects were included in this study.  Due to delay in shipping 
of blood samples, approximately one fourth of samples did not yield metaphase cells in culture 
and therefore could not be included in this study. A total of 484 (164 males and 320 females) 
blood samples were screened by FISH.  In addition, IRB approval was obtained to use discarded 
samples from the WVU cytogenetics clinical laboratory. An additional 81 (22 males and 59 
females) samples were selected on the basis of a normal karyotype at the 550 band level and a 
diagnosis excluding mental retardation, which were then de-identified prior to analysis. 
BLOOD LYMPHOCYTE CULTURE AND HARVEST 
One ml of blood was added to 7 ml of culture media (Appendix A) in a 15 ml sterile 
conical centrifuge tube and mixed by inversion. The culture was incubated for 72 hours at 37C.  
Ninety l of colcemid (Gibco Cat #757575) was added to each culture for 30 minutes.  The 
cultures were then centrifuged at 1200 rpm for 10 minutes.  Supernatant was removed by 
aspiration and 9 ml of hypotonic solution (0.075 M KCl) was added, mixed by inversion, and 
incubated at 37C for 10 minutes.  Following incubation, 3 ml of fixative (1:3 glacial acidic acid 
to absolute methanol) was added to each culture, mixed by inversion and centrifuged at 1200 
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rpm for 10 minutes.  Supernatant was removed by aspiration and the cell pellet was resuspended 
in 10 ml of fixative, mixed by inversion and centrifuged at 1200 rpm for 10 minutes.  The cell 
pellet was washed with fixative until the cell pellet was clean and white. The cultures were then 
stored at 4C.  
SLIDE PREPARATION 
The cell pellet was removed from a 4C refrigerator and brought to room temperature 
(RT).  After centrifugation, supernatant was removed and the cell pellet was re-suspended to an 
appropriate volume of fixative to obtain 5 or more metaphase cells per 10X field of view. 
Microscope slides were propped up at a 45 angle over a 73C steaming water bath.  Cells in 
suspension were dropped onto the top of the slide and allowed to run to the bottom. The slide 
was then placed horizontally until all fixative had evaporated and a grainy sheen was visible on 
the slide. The slide was removed from the water bath and allowed to air dry at room temperature 
in a slide rack.  
SUBTELOMERE FISH PROCEDURE  
The commercially available subtelomere FISH probe set ToTelVysion (cat# 33-270000, 
Abbott Molecular, Il) has been used in many recent studies (Li and Zhao, 2004; Iqbal et al., 
2005; Ravnan et al., 2006) and is currently used in the WVU cytogenetics laboratory.  The 41 
subtelomere probes are specific to the p and q subtelomeres of chromosomes 1-12, and 16-20, 
the q subtelomeres of the acrocentric chromosomes (13, 14, 15, 21, and 22), and the Xp/Yp and 
Xq/Yq pseudo-autosomal region subtelomeres.  The set consists of a mixture of CEP 
(Centromere Enumeration Probe) and LSI (Locus Specific) probes. Each of the 41 ToTelVysion 
probes hybridizes within 300 kb of the proximal end of the telomere, allowing for greater 
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sensitivity for detection of specific subtelomeric regions, and also minimizes cross hybridization 
with other subtelomeric regions with sequence homology. The probes range in size from 70 kb 
(17p) to as large as 191kb (5p). The probes are arranged in 15 sets that recognize 2-3 
subtelomeres per set (Table 3) Each probe and its clone ID are listed in Appendix B.   
Table 3. Probe sets included in the ToTelVysion probe panel. 
Set Subtelomere Locus and Fluorochrome 
1  1p Green,  1q Orange,  Xp/Yp Yellow, CEP X Aqua  
2  2p Green,  2q Orange,  Xq/Yq Yellow, CEP X Aqua 
3  3p Green,  3q Orange,  22q Yellow, LSI bcr (22q11) Aqua 
4  4p Green,  4q Orange,  21q Yellow, LSI AML (21q22) Aqua  
5  5p Green,  5q Orange  
6  6p Green,  6q Orange,  13q Yellow, LSI 13 (13q14) Aqua 
7  7p Green,  7q Orange,  14q Yellow  
8  8p Green,  8q Orange,  17p Yellow, CEP 17 Aqua 
9  9p Green,  9q Orange,  17q Yellow, CEP 17 Aqua 
10  10p Green,  10q Orange,  15q Yellow, LSI PML (15q22) Aqua 
11  11p Green,  11q Orange,  18p Yellow, CEP 18 Aqua 
12  12p Green,  12q Orange,  18q Yellow, CEP 18 Aqua 
13  16p Green,  16q Orange 
14  19p Green,  19q Orange 
15  20p Green,  20q Orange  
 
The prepared metaphase spread slides were washed in a series of 2X Saline Sodium 
Citrate (SSC) for 10 minutes at 37C, 1% formaldehyde for 15 minutes at room temperature 
(RT), 1X Phosphate Buffered Saline (PBS) for 5 minutes at RT, pepsin solution (Appendix A) 
for 13 minutes at 37C, 1X PBS for 5 minutes at RT and then air dried.  The slides were then put 
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through a series of ethanol washes of 70%, 85%, and 100% for 1 minute each and allowed to air 
dry at room temperature. 
Probe working solutions were prepared by adding 3l of ToTelVysion probe solution to 
30l of cDenHyb (InSitus, cat #D002) centrifuged briefly and vortexed in a microfuge tube. 
Three l of each working solution was placed in the middle of one of 5 respective circled areas 
on a slide. A 12 mm circular coverslip was placed on top and all air bubbles were driven out.  
When 5 spots per slide were completed, autoclave tape was placed across the entire slide and 
pressed firmly around the coverslips for a tight seal.  Slides were placed on a hotplate for 3 
minutes at 90C, transferred to a light-tight box, and incubated overnight in a 37C water bath.  
The next day, in a minimal light room, the slides were removed from the water bath and 
de-coverslipped. The slides were then washed in 0.4X SSC/0.3% NP-40 at 73C for two minutes 
and then for 30 seconds in 2X SSC/0.1% NP-40 at RT. The slides were completely air dried in 
the dark.  Twenty μl of 1X 4',6-diamidino-2-phenylindole (DAPI) counterstain was applied to 
the dried slides and coverslipped (20 mm X 50 mm). The slides were maintained in a light-tight 
box for transport to the microscope and storage for up to a week at 4°C.  
A Leica epi-fluorescent microscope equipped with a DAPI single bandpass, aqua single 
bandpass, and a red/green dual bandpass filter was used for signal enumeration. Yellow signals 
were read using the red/green filter.  Five metaphase and 5 interphase cells were scored for each 
probe set. 
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X/Y FISH PROBE PROCEDURE 
To confirm abnormal subtelomere FISH results regarding X chromosomes, slides were 
prepared as described above and co-hybridized with X and Y centromere probes.  One hundred 
interphase cells were analyzed for the number of X and Y centromere signals. 
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RESULTS 
Blood samples from a total of 565 phenotypically normal unrelated individuals were 
evaluated for cryptic rearrangements using subtelomeric FISH probes.  No balanced cryptic 
rearrangements were observed by FISH; all samples showed a normal location of signals. Since 
the frequency for a balanced cryptic rearrangement could not be based on observation, an 
estimate for the frequency of carriers for balanced subtelomere rearrangements (X) was 
calculated based on information from the literature using the following equation: 
(A)(B)(C)(D)(E)=X where A is the 2% of the population with MR (Baker et al., 2002), B is the 
50% of MR patients with unknown etiology (Flint and Wilkie, 1996), C is the estimated 5% 
incidence of subtelomeric abnormalities in MR patients with unknown etiology  (Walter et al., 
2004), D is the 50% percent risk of an unbalanced rearrangement being inherited from a parent 
with a balanced subtelomeric translocation (Knight et al., 1999), and E is the 50% chance that a 
carrier would have a child with an unbalanced rearrangement (due to segregation during 
meiosis). Using the above equation, the incidence of cryptic balanced subtelomeric 
rearrangement carriers in the general population who have affected children was estimated to be 
approximately 1 in 8000. 
 Among the specimens that were analyzed with subtelomeric FISH probe sets containing 
Xp/Yp and Xq/Yq, mosaicism for X chromosome aneuploidy was identified in 3 of 379 women 
(0.8%).  Using a separate X/Y centromeric probe set (specific for this probe), the FISH results 
were confirmed in interphase cells for these individuals: 89% triple X in a 36 year old, 5% triple 
X chromosome in a 52 year old, and multiple cell lines including 11% single X, 6% XXX and 
2% XXXX in a 54 year old (Fig. 7) (Table 4).  
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Table 4. X chromosome mosaicism in three individuals listed by age. The X columns show the percentage of cells analyzed that 





Mosaic Percentage of X chromosomes 
1X 2X 3X 4X 
1 36 - 11% 89% - 
2 52 - 95% 5% - 




Figure 7. FISH probe for the centromere of the X chromosome hybridized to interphase cells (A) A cell with one 
signal for the centromere of the X chromosome, or monosomy X. (B) Two normal cells showing two signals for the 




 No balanced cryptic translocations were found in the 565 subjects who were screened by 
subtelomere FISH probes.  From this sample size, it was not possible to determine the frequency 
of balanced subtelomeric translocation carriers.  Sample size was limited due to the number of 
individuals enrolled in the study who donated blood, culture failures and the cost of FISH 
probes. 
The calculated incidence of cryptic balanced subtelomeric rearrangement carriers in the 
general population is estimated to be approximately 1 in 8000.  Therefore, it was not surprising 
that cryptic balanced translocations were not identified among the 565 subjects in the study.  
The reported incidence of individuals with unbalanced subtelomeric rearrangements in 
the general population has been estimated to be 2.1 in 10,000 (~1 in 4762) by Knight et al., 
(1999).  Since half of these individuals inherited the rearrangement from a parent (Knight et al., 
1999; Adeyinka et al., 2005), the frequency of parents who are balanced translocation carriers 
would be half as frequent, or around 1 in 9524. The difference between the calculated estimate of 
1/8,000 and the estimate of Knight et al., 1999 is most likely due to the variation in the reported 
percentages and criteria for evaluation of MR.  Regardless, the incidence of balanced 
subtelomeric rearrangements is at least 10 times less prevalent than carriers of visible reciprocal 
translocations (1/600). 
33 
X CHROMOSOME MOSAICISM 
Individuals who are mosaic have two or more populations of somatic cells that are 
genetically different.  Aneuploidy of the X chromosome can arise by mitotic nondisjunction or 
anaphase lag.  There are several factors to consider when observing low level mosaicism: are the 
results due to genuine mosaicism, technical artifact or age related? 
In tissue culture artifacts the gain of the X chromosome has been shown to occur in less 
than 1 in 2500 cells (Wenger et al., 1984).  For this study tissue culture artifact has also been 
ruled out because previous FISH studies have shown that cultured lymphocytes reflect in vivo 
aneuploidy rates and that there is no significant difference between cultured lymphocyte and 
uncultured lymphocyte stability (Guttenbach et al., 1995 and Catalán et al., 2000). 
Age related X chromosome aneuploidy has been attributed to premature centromere 
division in older women.  Several studies have demonstrated that peripheral blood metaphase 
cells from women generally 50 years of age and older could have an average of 4-5% X 
chromosome loss and less than 1% X chromosome gain attributed to mitotic error (Jacobs et al., 
1961; Fitzgerald, 1975; Ford and Russell, 1985; Abruzzo et al., 1985, Russell et al., 2007). This 
finding has been substantiated in interphase cells using FISH probes, demonstrating that women 
older than 60 years of age had an average X chromosome loss of 3.4% (as high as 9%) and gain 
of less than 1% (Guttenbach et al., 1995; Mukherjee, et al., 1996). 
All 3 of the individuals identified with mosaicism in this study had gains of X 
chromosomes. Although two of the three women were over the ages of 50, all of these women 
had a cell line with 5% or greater for an extra X chromosome. Because age related aneuploidy in 
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females usually involves loss of the X chromosome in lymphocytes, this would suggest that the 
cells with a gain of an X chromosome are not related to age or tissue culture artifact.  
The incidence of sex chromosome mosaicism in the general population is from studies in 
the literature from the late 1970s. These reports used newborn or prenatal populations, with 
limited number of analyzed metaphases. A representative study reported 0.1% aneuploidy for sex 
chromosomes in newborn studies based on analysis of 3-5 cells (Hook and Hamerton 1977).  By 
screening the general population with FISH, many more cells could be screened by FISH than 
with karyotypes. 
The finding of mosaicism in 0.8% of women suggests that numerical abnormalities of the 
X chromosome may be more common in females than previously reported. This underreporting 
is most likely due to lack of an abnormal phenotype.  Individuals who have low level mosaicism 
for the X chromosome are less likely to have a clinically relevant phenotype and therefore would 
go undiagnosed in the general population. 
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CONCLUSIONS 
Based on a review of the literature, the incidence of cryptic translocation carriers is 
estimated to be approximately 1/8,000, which is 10 times less prevalent than the frequency of 
visible reciprocal translocations. While no balanced subtelomeric rearrangements were 
identified, three females in this study were determined to be mosaic for the X chromosome. 
Mosaicism for XXX cell lines were observed in the lymphocyte cultures of 3 in 379 women 
(0.8%), which is a higher frequency than the 1 in 1000 (0.1%) reported for sex chromosome 
aneuploidies.  These findings suggest that numerical abnormalities of the X chromosome are 
more common in females than previously reported.  
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FUTURE STUDY AND LIMITATIONS 
Sample size of the project was reduced due to a large number of blood samples with no 
growth. This was most likely due to long shipping delays. The blood collection took place in 
multiple locations off site and samples were frequently held several days for batch shipping.  
More than 150 of the samples were received up to two weeks after collection of the sample.  
Reduced mitotic indices occur after four days due to death of lymphocytes.  
Sample size was also limited to those who chose to donate blood.  Many individuals with 
a family history of MR or other factors that may be indicative of a chromosomal imbalance such 
as multiple miscarriages, did not choose to have themselves or their children donate blood.  This 
is assumed to be for reasons of preventing undue stress from an invasive procedure. 
This study could have been improved by minimizing delay in shipping specimens from 
the study sites and by encouraging individuals to donate blood.  If rearrangements were detected, 
it would have been interesting to use array CGH (discussed in detail in chapter three) to detect 
the size of the deletion and/or duplication.   
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CHAPTER THREE 
SUBTELOMERIC DELETIONS: THE IMPORTANCE OF RULING OUT 
POLYMORPHIC VARIANTS OR INHERITED DELETIONS 
INTRODUCTION 
Numerous studies have reported cryptic subtelomere chromosome imbalances in patients 
with unexplained MR or DD identified by FISH.  Incidence reports of subtelomere imbalances 
vary greatly, depending on sample size and the stringency of the criteria for patient selection.  In 
general, subtelomeric imbalances have been identified in 3-10% of individuals with idiopathic 
mental retardation (IMR) and a normal karyotype (Knight et al., 1999; Anderlid et al., 2002; 
Bocian et al., 2004).  Several checklists have been developed that provide common guidelines 
for patient selection (de Vries et al., 2001; Walter et al., 2004), which gives a higher sensitivity 
for detection. 
However, not all subtelomeric imbalances are necessarily disease causing.  Benign 
subtelomeric polymorphisms have been reported since 1991 (Wilkie et al., 1991).  For example, 
there is a common polymorphism on chromosome 2q where alleles had a 55kb difference in 
length (Macina et al., 1994).  Additional common polymorphisms have been identified at the 4q 
and 10q subtelomere regions (Wong et al., 2005). In a large study of patients with IMR (Ravnan 
et al., 2006), 0.5% of all of imbalances observed by FISH were found to be polymorphic 
variants. The most common variants were deletion or duplication of 10q, deletion of 4q, deletion 
of Yq, deletion of 2q, and duplication of Xp/Yp onto Xq.   
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OBJECTIVES 
 Many studies have reported the incidence of individuals with MR and a normal karyotype 
who have a FISH-identified cryptic rearrangement that range from 2.5 to 10%, depending on 
criteria used for selection.  The objective of this study was to retrospectively determine the 
frequency of individuals in a clinical population who had abnormal results by subtelomere FISH. 
In this study log books from the West Virginia University cytogenetics laboratory were reviewed 
for individuals with IMR and a normal karyotype, to determine the frequency of these 
individuals who had abnormal subtelomere results by FISH. Additionally, records were searched 
to determine if the parents were tested for the same abnormality, and if one of the parents had the 
same abnormality as the child, parental medical records were checked for incidence of an 
abnormal phenotype.  This study will determine the importance of parental testing in 
confirmation of subtelomeric abnormalities and polymorphisms.  
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MATERIALS AND METHODS 
Institutional Review Board (IRB) approval was obtained to review cytogenetics 
laboratory records from December 2001 to December 2007 for subtelomere FISH performed on 
patients with MR/DD and a normal G-banded karyotype.  A total of 256 patients were found to 
fit these criteria. Medical records were examined for those with abnormal FISH results. 




 Blood samples from two hundred and fifty six pediatric patients were evaluated for 
subtelomere rearrangements using FISH probes.  These patients had MR or DD as well as 
diagnoses including seizures, autism, short stature and microcephaly.  Nine, or 3.5%, of these 
patients had abnormal results: 5 with deletions and 4 with deletion/duplications. Of the five 
terminal deletions identified in this study, two were inherited.  Although requested, parental 
blood was not received for the other submicroscopic deletions for 3p, 5q and 15q22, which have 
previously been reported with an abnormal phenotype (de Vries et al., 2003; Ravnan et al., 
2006). Four derivative rearrangements were detected of which two were known to be inherited 
by a parent and one was de novo. Two polymorphisms (0.78%) were detected. One of the 
polymorphisms was a 4q deletion, while the other was an additional 16q subtelomere signal on 
18p shown to have a normal signal pattern using Cytocell probe for 16q. 
















Patient 1 - 46,XY.ish del(3)(p25)(D3S4559-) 
 Patient 1 was born at 41 weeks gestation with a birth weight of 7 pounds 6 ounces. He 
did not walk until age 2 and had delayed speech.  He was in the 25th percentile for height and 
weight and the 10th percentile for head circumference. He was referred for genetic evaluation at 
age 4 for his developmental delays.  He presented with bilateral ptosis and a right nasolacrimal 
duct obstruction.  Subtelomere FISH revealed a terminal deletion of the short arm of 
chromosome 3 (Fig. 8). His family history included an aunt who had multiple miscarriages. Both 
parents had declined to be karyotyped.  
 
Figure 8.  One 3p probe signal is absent indicating a deletion of 3p. 
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Patient 2 - 46,XY.ish del(4)(4q35)(D4S2930-)mat 
 Patient 2 was born at 38 weeks gestation, weighed 6 pounds and was 18 ¼ inches long.  
He was hospitalized twice before 3 months of age due to cyanotic episodes.  An atrio-ventrical 
(AV) defect was identified prenatally by ultrasound, and was repaired at 3 months of age.  At 2.5 
years of age he was 33.75 inches long (5th percentile), weighed 23 pounds, 4 ounces (<1/3 
percentile), and his head circumference was 47.2 cm (10th percentile). He had a high forehead, 
posterior displaced hair whorl, small palpebral fissures, and a café au lait spot. His muscle tone 
was lower than average.  Subtelomere FISH revealed a terminal deletion of the long arm of 
chromosome 4 that was found to be inherited from his mother (Fig. 9).  His mother, father and 
paternal grandfather all were diagnosed with Ehlers-Danlos syndrome, however, he did not 
exhibit any symptoms. His mother had hearing loss due to multiple ear infections, mitral valve 
prolapse, and had attended special education.  His maternal uncle was in special education. 
 
Figure 9. One 4q probe signal (red) is absent indicating a deletion of 4q . 
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Patient 3 - 46,XX.ish del(5)(p15.3)(C84C11-)pat 
 Patient 3 was born 10 days late by C-section secondary to poor progression and decreased 
heart rate.  She weighed 8 pounds 3 ounces at birth. She was a poor eater who choked easily.  
Her language was delayed and she was late-developing in every area. She did not maintain eye 
contact and did not tolerate loud noises. She was referred for genetic evaluation after an initial 
diagnosis of autism.  At 33 months she communicated on a level of less than a 12 month old.  
Her social and emotional skills were determined to be at less than 12 months. Her gross motor 
skills were at 24 to 36 months and her fine motor skills were at 12 to 18 months.  Subtelomere 
FISH revealed a terminal deletion of the short arm of chromosome 5 (Fig. 10) that was inherited 
from her father.  Some members of her mother’s family had required special education and 
another was diagnosed with bipolar disorder. The father was slow, had been enrolled in special 
education, had scoliosis, microcephaly and a heart murmur. The paternal grandmother reported 





Figure 10.  One 5p probe signal (green) is absent indicating a deletion of 5p. 
Patient 4 - del(5)(q35)(GS3508/T,5QTEL703-) 
Patient 4 was adopted at 6 months of age, sat at 9 months, walked at 14 mo, and was 
toilet trained at 2.5 yr of age.  At 3.5 yrs he weighed 32.7 lb (50th percentile), his height was 
40.5" (50th percentile) and head circumference was 50 cm. He had a phenotype and 
developmental problems of fetal alcohol syndrome. He was knock-kneed and had 
trigonocephaly.  He had behavior problems and was hyperactive. Subtelomere FISH revealed a 
deletion of 5q35 (Fig. 11).  Family history was not available. 
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Figure 11. One 5q probe signal (red) is absent indicating a deletion of 5q. 
 
Patient 5 - del(15)(q22)(PML dim) 
Patient 5 was delivered by C-section with a birthweight of 9 lb 1 oz, and length of 21 
inches.  He  had a repair of cleft lip/palate at 1 yr of age. He also had recurrent ear infections and 
the mother did not think he was significantly delayed until kindergarten. In the 5th grade he was 
achieving at 3rd grade level. IQ testing showed mild MR. At 12 1/5 years of age his weight was 
90th percentile, height 75th percentile, head circumference 95th percentile. He has synophrys 
with a heavy brow, mild ptosis, broad nasal bridge and slightly tapered fingers. Subtelomere 
FISH revealed a diminished signal of 15q22 indicating a deletion (Fig. 12). Family history 
includes mother's second child died at 11 hrs of life from probable heart defect. Father has 
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siblings with significant intellectual impairment and a nephew with cleft lip and palate.  The 
mother had normal size signals, but the father was not tested. 
 
Figure 12. One 15q probe signal (red) is diminished indicating a deletion of 5q22. 
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SUBTELOMERIC DERIVATIVE REARRANGEMENTS 
Patient 6 - 46,XX.ish der(4)t(4;8)(p16;p23)(GS10K2-,D8S504+)dn 
 Patient 4 was born full term with a weight of 4 pounds, a length of 16.25 inches, and a 
head circumference of 29 inches.  At 2 weeks of age, all of her measurements were below the 5th 
percentile.  She was diagnosed with intrauterine growth retardation, cleft lip, cleft palate, a 
dysplastic iris, a flat nasal bridge, simple ears, heart defects, and a depressed chin.  She had 
bilateral clinodactyly and was hypertonic.  Subtelomere FISH revealed a de novo rearrangement 
between 4p and 8p, resulting in loss of 4p subtelomeric region and duplication of 8p 
subtelomeric region (Fig. 13 and Fig. 14).  No family history was available. 
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Figure 13.  One 4p probe signal is absent indicating a deletion of 4q. 
 
Figure 14.  There are 3 probe signals for 4q indicating a duplication of 4q. 
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Patient 7 - 46,XY.ish der(9)t(9;10)(p24;p15)(305J7-,Z96139+)pat 
 Patient 5 was a 1-year-old male presenting with seizures, developmental delays, 
decreased reflexes, and hypotonia.  He was unable to walk or crawl.  He was below the 3rd 
percentile for length and was slow to gain weight.  He had a heart murmur and abnormal eye 
movements with his left eye deviating inward.  Subtelomere FISH showed a derivative 
chromosome 9 that was inherited from his father who was found to have balanced translocation, 
resulting in deletion of 9p subtelomeric region and duplication of 10p subtelomeric region (Fig. 
15 and Fig. 16). The patient had a brother in good health. 
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Figure 15.  One 9p probe signal is absent indicating a deletion of 9p. 
 
Figure 16.  There are 3 probe signals for 10p indicating a duplication of 10p. 
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Patient 8 - 46,XY.ish der(12)t(7;12)(q36;p13)(7QTEL203-,8M16+) 
 Patient 6 was born at full term with a birth weight of 7 pounds 8 ounces. He had delayed 
speech and did not walk until 2.5 years. He was toilet trained at 5 years of age. At 6 years of age 
he was autistic, had a mild Dandy-Walker variant malformation of the brain, and was 
microcephalic.  All of his measurements were below the 5th percentile.  He was hirsute and his 
speech was echolalic. He had a sebaceous adenoma of the left parietal area, a low anterior and 
posterior hairline, and slightly low set ears. He had difficulty with fine motor skills.  He was 
polite and liked to help when he could.  He engaged in self stimulating behaviors, did not make 
eye contact, and disliked loud sounds. He was seen by a speech language pathologist, but did not 
respond well. He was delayed socially and emotionally.  Telomere FISH revealed a derivative 12 
chromosome with deletion of 12p subtelomeric region and duplication of 7q subtelomeric region 
(Fig. 17 and Fig. 18).  His mother has social anxiety problems, obsessive-compulsive disorder, 
and sociopathic tendencies.  The father has several nieces with unknown mental impairments. 




Figure 17. One 12p probe signal is absent indicating a deletion of 12p. 
 
Figure 18. There are 3 probe signals for chromosome 7q indicating a duplication of 7q. 
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Patient 9 - 46,XY.ish der(15)t(15;18)(q26;q23)(D15S936-,D18S1390+)mat 
 Patient 7 was born after 38 weeks gestation from an uncomplicated pregnancy.  At birth, 
his weight was 4 pounds and 10 ounces and his length was 17 ½ inches.  He first crawled and 
spoke at 1 year of age, but quit speaking soon thereafter.  He was referred for genetics evaluation 
at 13 months of age for a receding chin, short stature, bicuspid valve problems, hypertonia, 
single palmar creases, and 5
th
 digit camptodactyly.  His mother had a history of miscarriages.  He 
had one half-sibling who had an 18q deletion.  FISH results showed a derivative chromosome 15 
with deletion of 15q subtelomeric region and duplication of 18q subtelomeric region (Fig. 19 and 
Fig. 20). The derivative 15 was inherited from his mother, who had a balanced translocation. 
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Figure 19. One 15q probe signal is absent, indicating a deletion at 15q 
 
Figure 20. There are 3 probe signals for chromosome 18q indicating duplication of 18q . 
55 
POLYMORPHISMS 
Polymorphisms are ruled out by testing the same sample with another FISH probe which 
has a different sequence arrangement and binding specificities.  A rearrangement/deletion can be 
ruled a polymorphism if one probe identifies it as abnormal and it is not confirmed abnormal 
with a second probe, or a parent with a normal phenotype has the same abnormality identified by 
FISH. 
Two polymorphisms were detected. One of the polymorphisms was a 4q deletion (Fig. 
21), which has previously been reported (Ravnan et al., 2006), while the other was an additional 
16q subtelomere signal on 18p (Fig. 22), shown to have a normal signal pattern using Cytocell 
probe for 16q.  
 




Figure 22.  There are three 16q signals (red)  indicating a duplication of 16q on to chromosome 18.  Upon testing with a second 
probe this was found to be a polymorphism. 
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DISCUSSION 
In 2005 the American College of Medical Genetics published guidelines for the 
cytogenetic evaluation of individuals with DD or MR. They recommended that if no 
chromosome abnormality is found at the 550 band level, subtelomere FISH was appropriate 
(Shaffer, 2005). Following identification of deletion and/or duplication, standard procedure is to 
confirm deletions or duplications with an alternative probe from another manufacturer and 
request parental blood to rule out inheritance of a polymorphism.  The detection rate of 
abnormalities associated with polymorphisms in this study population was 0.78%, which is 
similar to the 0.5% for all types of polymorphic variants identified in a large study (Ravnan et 
al., 2006). 
Previous reports in the literature have shown that 3-10% of individuals with idiopathic 
MR and a normal karyotype had subtelomere rearrangements (Knight et al., 1999; Anderlid et 
al., 2002; Bocian et al., 2004).  In the largest published study, deletion or deletion/duplication 
was identified in 2.5% of the evaluated population.  These results fall on the lower end of the 
reported range, suggesting that the criteria for choosing patients were not strict (Ravnan et al., 
2006). 
For this population, results showed more than half of subtelomere deletions and 
rearrangements were transmitted by a parent (4 out of 5 with parental testing), which is 
consistent with what has been reported in the literature (Knight et al., 1999; Adeyinka et al., 
2005; Ravnan et al., 2006).  
Inheritance of subtelomere deletions may be more common than previously recognized.  
Few reports have indicated deletions inherited by an affected parent.  Adeyinka et al, identified 
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reported that among 28 patients with deletions, 9 (32%) had an inherited deletion, whereas 19 
(68%) were de novo.  Recently, three more instances of inherited subtelomere deletions have 
been reported, involving 5p and 6q (Samanich et al., 2008; Dalton et al., 2008, Fang et al., 2008). 
This further emphasizes the importance of testing parents and knowing their phenotype to rule 
out polymorphisms or to provide counseling for recurrence risk.  
In this study, two of the terminal deletions were inherited from parents who had an 
abnormal phenotype.  The use of FISH to identify cryptic chromosome rearrangements and 
deletions has been very successful.  However, like all assays, FISH has its limitations (Kaiser-
Rogers et al., 2000).  FISH requires an initial knowledge of what genetic disorder is suspected. 
For example, if a patient presents with the classic phenotype of Angelman syndrome, a probe for 
15q11.2 can be used to confirm the diagnosis.  However, a large number of individuals do not fit 
within a categorically recognizable phenotype. To detect the possible genetic cause of an 
unrecognized phenotype resulting from a chromosome disorder, a better screening tool is 
required. 
 Based on its recent successes, aCGH (array comparative genomic hybridization) will 
likely replace FISH for screening in prenatal and pediatric genetic diagnostics.  Subtelomere 
FISH is currently rarely requested.  For example, aCGH has been successful in detection of 
disorders in as little as one ml of amniotic fluid and does not need cultured cells (Rickman et al., 
2006). Numerous studies have used aCGH to identify microdeletions for targeted areas of the 
genome (Harada et al., 2004; Tyson et al., 2004; 2005; Iqbal et al., 2005; Ballif et al., 2006; Bar-
Shira et al., 2006; Kitsiou-Tzeli et al., 2007) or whole genome screening (Veltman et al., 2002; 
de Vries et al., 2005; Bauters et al., 2005;  Le Caignec et al., 2005; Schoumans et al., 2005; 
Lugtenberg et al., 2006; Rosenberg et al., 2006).  Many others have shown that interstitial 
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deletions and expanded subtelomere resolution are clinically diagnostic (Kirchoff et al., 2004; 
Friedman et al., 2006; (Krepischi-Santos et al., 2006; Ballif et al., 2007).  Recent American 
College of Medical Genetics guidelines (Manning and Hudgins, 2007) suggest that aCGH be 
used as an adjunct for screening patients who have MR or multiple congenital abnormalities. 
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CONCLUSIONS 
In conclusion, nine out of 256 (3.5%) patients had abnormal subtelomere FISH studies, in 
which five were deletions and four were deletion/duplications.  In addition, two polymorphisms 
(0.78%) were identified. Parents for two of the five patients with deletions were tested and found 
to have the same deletion as their child (patients 2 and 3), and a similar abnormal phenotype. 
Two of four individuals inherited their derivative rearrangement/deletion from a parent who was 
a balanced carrier (patients 7 and 9). These results emphasize the importance of parental testing 
as well as contact with the clinician in order to interpret the deletion as a polymorphism or 
inherited through an affected parent, the latter which may be more common than previously 
thought. 
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FUTURE STUDY AND LIMITATIONS 
 It would have been beneficial to have more family history and FISH results from the 
parents of patients 1, 4, 5 and 8, none of which had complete immediate family information.  
This would have given better data for the inheritance of rearrangements.  Performing aCGH on 
individuals, including immediate family members would have the potential to reveal additional 




TELOMERE LENGTH STUDIES OF INDIVIDUAL HUMAN 
CHROMOSOME ARMS  
 
INTRODUCTION 
 The human telomere is a highly repetitive GC rich protective structure located at the 
terminal regions of the chromosomes.  The telomere “caps” the ends of chromosomes to prevent 
end-to-end fusions, which could result in whole chromosome and segmental aneuploidy.  The 
inverse relationship between overall telomere length and its role in ageing and premature ageing 
diseases has been well documented (Shay and Wright, 2001; 2007).  However, only a few studies 
have examined the length of telomeres for individual chromosome arms in humans. 
 Lansdorp and colleagues (Lansdorp et al., 1996) had found that the telomere length for 
sister chromatids was similar in cells from different tissues; however, the distribution of telomere 
length between chromosomes was not random.  Martens and colleagues (Martens et al., 1998) 
found that there was a significant difference between the telomere length of individual 
chromosome arms, with a weak positive correlation between the length of chromosome arms and 
the corresponding telomeres. Graakjaer and colleagues (Graakjaer et al., 2003; 2004; 2006a; 
2006b) had found that human telomere length correlated well with chromosome length but did 
not have as strong a correlation with individual chromosome arm size. 
Telomere length has been quantified by several methods including direct sequencing, 
Southern blot based methods, flow cytometry, three-dimensional confocal microscopy, and 
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Quantitative FISH (Q-FISH) (Figs. 23 and 24) (Hultdin et al., 1998; Uhlmann et al., 2000; 
Slijepcevic, 2001; Baerlocher et al., 2002; Perner et al., 2003).  Q-FISH uses Peptide Nucleic 
Acid (PNA) probes to bind to the telomere repeat.  A PNA probe consists of a peptide sequence 
that can bind to specific DNA sequences much like a DNA binding domain within a DNA 
binding protein.  
The advantages of a PNA probe are having a shorter hybridization time due to absence of 
a charge and being less prone to nonspecific binding. The PNA probe is coupled with a 
fluorescent dye and works much the same way as a DNA FISH assay. Theoretically, PNA FISH 
has a resolution of 300 bp (Aubert and Lansdorp, 2008).  However, like most assays the accuracy 
of the measurements depends on quality of the chromosome preparation and the condition of the 
instrumentation collecting the images. 
 
Figure 23.  Grayscale image of a hybridized metaphase spread showing Q-FISH probe fluorescence at each telomere and the 
centromere reference probe on chromosome 2. 
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The purpose of this study was to examine telomere length of individual chromosome 
arms in metaphase cells from cultured lymphocytes of 17 individuals using quantitative 
fluorescent in situ hybridization (Q-FISH) and to make comparisons to the physical length of the 
chromosome arm.  Previous studies have shown correlations to chromosome arm size, however 
none have fully investigated these relationships in any great detail.  Q-FISH for telomere length 
was performed using peptide nucleic acid (PNA) probes which are highly specific and provide a 
high resolution (Slijepcevic, 2001) allowing for quantitative measurement of telomeres by 
digitally measuring the intensity of probe signals on metaphase chromosomes against a reference 
probe.  Rather than relying on the photographic size by measurement of each chromosome arm 
in photographs, the length of each chromosome arm in Mb was obtained from the National 
Center for Biotechnology Information (NCBI) map viewer website. 
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MATERIALS AND METHODS  
 Subjects for this study were drawn from the Center for Oral Health Research in 
Appalachia (COHRA; Polk et al., 2008), an ongoing cross-sectional oral health etiology study.  
COHRA ascertains families from two central West Virginia counties and two western 
Pennsylvania counties and performs a detailed assessment protocol after an informed consent 
process approved by the IRBs of the University of Pittsburgh and West Virginia University. 
 Seventeen COHRA subjects were included in the study: 8 male and 9 female, with ages 
ranging from 2 to 45 years of age, average age 18.9 years (median 15 years). Telomere lengths 
were measured in a total of 76 metaphase cells from 17 individuals giving a total of 152 
individual measurements for each chromosome arm (with the exception of the X (n=120) and Y 
(n=32) chromosomes).  No consideration was given for relationship. 
Peripheral blood lymphocytes were processed using standard cytogenetic techniques 
(described in Chapter 1). Cells were dropped onto slides, which were then immersed for: 2 min. 
in Tris Buffered Saline (TBS), 2 min. in 3.7% formaldehyde in 1X TBS, 10 min. in TBS, 10 min. 
in Pre-Treatment solution (DAKO, Glostrup, Denmark) and 10 min. in TBS. The slides were 
immersed through a series of ethanol washes of 70%, 85%, and 100% for 1 min. each and then 
allowed to air dry at room temperature. 
 Hybridization protocol was followed as provided by the manufacturer (DAKO). Ten l of 
FITC PNA telomere probe mix (DAKO) and FITC PNA chromosome 2 centromere probe 
(courtesy of DAKO) was added to prepared slides, coverslipped and sealed with tape. The probe 
and chromosome preparation were codenatured for 5 min. at 80 C and placed in the dark at 
room temperature for 30 min. Slides were immersed in the supplied rinse solution (DAKO) for 1 
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min. to remove coverslips. The slides were washed in the supplied wash solution for 5 min. at 
65 C. The slides were then dehydrated by immersion through a series of ethanol washes of 70%, 
85%, and 100% for 1 min. each and allowed to air dry at room temperature.  Twenty μl of 1X 
DAPI counterstain (In Situs, Albuquerque, NM) was applied to the dried slides and coverslipped 
(20 mm X 50 mm).  
Metaphases were photographed using ISIS (MetaSystems, Altlussheim, Germany)  
software on a Leica epi-fluorescent microscope equipped with a DAPI single bandpass, and a 
FITC single bandpass filter.  The images were then background corrected, and the color channels 
were placed in inverted grayscale mode, approximating a G-banding pattern to allow for easier 
karyotyping. 
 The telomere measurement software package from MetaSystems was used to quantify 
telomere length on the p and q arms of each chromosome relative to the reference signal on 
chromosome 2. Measurements were reported as arbitrary units of Relative Telomere Length 
Units (RTLU), which is the ratio of telomere signal intensity to the centromere 2 reference 
signal. The size of each chromosome arm (measured in Mb) was estimated from data provided 
online from the National Center for Biotechnology Information (NCBI) Map Viewer (NCBI, 
2008). 
Relative telomere length measurements were plotted against the size of the corresponding 
chromosome arm. Regression analysis was performed and correlation coefficients were 
calculated. P values were obtained from the regression analysis. 
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RESULTS 
TELOMERE LENGTH AND AGE OF SUBJECTS 
The total telomere length from 17 individuals was measured and averaged. Fig 25 shows 
average telomere length plotted against the age of the individual in years. The regression line 




Figure 25.  Telomere length and age. Overall telomere length is plotted against age showing the trendline of age and 
telomere length.  
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TELOMERE LENGTH AND CHROMOSOME ARM SIZE 
 Chromosome arm length in Mb was compared to telomere length (RTLU) for each 
chromosome arm for each individual in this study to see if a consistent pattern was observed 
from individual to individual (Table 6). Direct correlation was found for all individuals; 
statistically significant correlations were seen in 11 of 17 (65%). Three of the remaining 6 were 
close to the 0.05 cutoff for significance. 
 Due to consistency of the relationship between lengths for telomeres and chromosome 
arm lengths among individuals, the data were pooled for each chromosome arm to determine the 
mean value for each corresponding telomere ratio to the centromere signal, RTLU. After pooling 
of data, average telomere length (RTLU) was compared to chromosome arm size (in Mb) using 
bivariate analysis. The result was a highly significant (p<0.0001) correlation (Fig. 26).  The 
overall data had a positive correlation coefficient (r) of 0.60 (Table 7).   
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Table 6.  Average telomere length for each individual in the study with associated p values.  A bivariate fit of average telomere 
length by chromosome size (in Mb) was performed to correlate the relationship between physical chromosome size and relative 
telomere length, and had a highly significant (p<0.0001) positive correlation. n is equal to the number of measurements per 
chromosome. 





1 Female 7 6 14.96 0.0107* 
2 Female 15 8 14.24 0.006* 
3 Female 9 16 15.88 0.4061 
4 Female 9 6 17.67 0.0575 
5 Female 5 20 11.44 0.0008* 
6 Female 6 6 13.12 0.0686 
7 Male 45 8 10.39 0.0338* 
8 Male 39 4 14.91 0.3145 
9 Male 34 6 12.14 0.019* 
10 Male 35 10 8.91 0.1919 
11 Female 36 16 9.02 0.0094* 
12 Female 28 4 17.28 <0.0001* 
13 Female 33 6 14.46 0.0252* 
14 Male 12 12 10.33 0.0086* 
15 Male 6 8 13.29 0.0506 
16 Male 15 8 9.65 0.0161* 
17 Male 4 8 9.25 0.0259* 
Overall   152  <0.0001* 













2q 149.7 10.55 3.53 
4q 140.2 14.02 4.24 
5q 133.3 13.13 3.84 
1p 124.3 14.38 3.42 
1q 122.7 13.24 4.33 
6q 110.5 13.53 3.42 
3q 108.3 13.00 3.12 
8q 100.8 13.55 3.80 
7q 99.9 14.00 4.91 
13q 98.0 13.82 3.72 
12q 96.6 13.14 3.98 
Xq 95.5 12.64 4.51 
10q 94.7 14.04 5.20 
2p 93.3 12.74 3.99 
3p 91.7 14.46 3.96 
14q 90.4 13.29 4.81 
9q 88.2 11.83 3.31 
15q 83.0 12.52 3.00 
11q 81.1 14.23 4.20 
6p 60.5 11.53 4.24 
18q 59.9 12.24 3.28 
Xp 59.5 13.92 4.70 
7p 59.1 12.57 3.93 
17q 56.8 10.82 4.39 
11p 52.9 12.22 5.11 
9p 51.8 11.62 3.97 
16q 50.8 11.78 4.23 
4p 50.8 13.32 3.20 
5p 47.7 12.74 3.65 
Yq 46.7 6.75 2.29 
8p 45.2 12.87 3.78 
10p 40.3 11.45 2.53 
16p 38.2 11.28 3.23 
22q 38.2 11.19 3.79 
19q 35.5 10.38 3.47 
12p 35.4 10.62 3.92 
20q 34.9 10.18 3.61 
21q 34.7 10.87 3.33 
19p 28.5 9.82 3.18 
20p 27.1 12.76 3.26 
17p 22.2 10.69 3.72 
15p 17.0 11.57 3.52 
18p 16.1 11.57 3.63 
13p 16.0 11.46 4.53 
14p 15.6 11.24 3.05 
21p 12.3 10.60 3.63 
22p 11.8 10.24 4.39 





Figure 26.  Chromosome arm values, measured in Mb pairs, are plotted against relative telomere length in RTLU from Table 7.  
The linear regression line corresponds to a correlation coefficient of 0.6 and p<0.0001 
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DISCUSSION 
CORRECTING FOR CHROMOSOME VARIABILITY 
 This study relied heavily on the accurate measurement of telomere length and physical 
chromosome arm length.  Standardized chromosome arm measurements were taken from the 
NCBI map viewer website to correct for the variability that occurs when measuring 
chromosomes by photographic means and the variation in chromosome condensation.  This 
approach has not been documented elsewhere.  
TELOMERE LENGTH AND AGE  
The erosion of telomere length with increasing age has been well documented (Chiu and 
Harley, 1997; Filatov et al., 1998; von Zglinicki et al., 2000; Aragona et al., 2000; Goyns and 
Lavery, 2000; Martens et al., 2000; Shay and Wright, 2001; Yang et al., 2001). In this study, 
telomere length showed a trend to shorten with increased age of subject. However, the 
insensitivity of this assay and the young average age of the individuals studied did not yield 
statistically significant correlations, since there was not enough age difference to obtain the 
necessary sensitivity.  
In general, studies of telomere length have used individuals who are the oldest and the 
youngest 5% of the population (Harley et al., 1990; Bischoff et al., 2005a; 2005b; Graakjaer et 
al., 2006a).  The difference in age of the oldest and youngest individual in this study was only 43 
years of age.  It is difficult to obtain enough sensitivity with PNA FISH or any other assay 
(Hultdin et al., 1998; Uhlmann et al., 2000; Slijepcevic, 2001; Baerlocher et al., 2002; Bekaert et 
al., 2002; Perner et al., 2003; de Pauw et al., 2005) to detect a statistically significant difference 
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in overall telomere length without a greater range of ages in the sample.  However, a strong but 
not statistically significant (f=0.18) negative correlation (r= -0.48) was observed. 
TELOMERE LENGTH AND CHROMOSOME ARM SIZE  
In this study, the telomere length for each chromosome arm was measured to help clarify 
the relationship of telomere length to the size of chromosome arm, since few studies have 
examined this relationship in detail.  The data showed that telomere length directly correlates to 
the length of the chromosome arm.   
Only two research groups have examined the telomere length profile in humans with 
regard to chromosome arm size.  Martens and colleagues (Martens et al., 1998) found a weak 
positive correlation between human chromosome arm size and corresponding telomere length; 
however, they did not show their data and only briefly commented on the findings between 
human chromosome arm size and corresponding telomere length.  Overall, the data of this study 
using Mb had a correlation coefficient of 0.60, similar to results of 0.51 and 0.79 reported using 
physical measurement of chromosome arms (Graakjaer et al., 2003; 2004; 2006a)   
Several studies have found statistically significant correlations of p and q telomere length 
to the total size of each chromosome (summation of p and q arms) (Martens et al., 1998; 
Graakjaer et al., 2003; 2004; 2006a; 2006b).  Comparison of data in this study for whole 
chromosomes (summation of p arm and q arm size in Mb pairs and correlation to average 
individual telomere length for those arms from Table 7) showed a similar statistically significant 
correlation (p<0.0001).   
The correlations of telomere length with chromosome arm size and total chromosome 
size would be expected since the summation of p and q chromosome arm size and the summation 
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of p and q telomere length would show the same proportional relationships as single arm and 
single telomere measurements.  Because of this property, the correlation with the arm rather than 
the entire chromosome suggests that individual telomere length to chromosome arm size is the 
functional relationship, but does not exclude the possibility of a combination of effects from both 
relationships.  It is also important to keep in mind that correlation does not necessarily indicate 
causation. 
 In 2002, Sridevi et al. examined the telomeres of three species of Fountain grass 
(Pennisetum).  One species had a longer average chromosome length than the other two species, 
while the other speciens had chromosomes that were all close to the same size.  The species that 
had longer chromosomes had longer telomeres when compared to the species with shorter 
chromosomes.  In the species where the chromosomes were all about the same size, individual 
telomere lengths were all about the same.  This suggests that the trend of larger chromosomes 
having longer telomeres may be present across species even as evolutionarily distant as Fountain 
grass from human.  Non-human studies using mouse models (Zijlmans et al., 1997), Chinese 
hamster models (Slijepcevic et al., 1998), and plant Pennisetum glaucum (pear millet) (Sridevi et 
al., 2002) have demonstrated correlation between telomere length and chromosome arm size.  
These findings are important because, along with human studies, they demonstrate that 
chromosome arm size and telomere length relationships have been conserved by evolution.  
Evolutionary conservation may suggest a greater functional relationship rather than structural 
stability.  To further understand telomere-chromosome relationships it may be beneficial to 
examine telomere length in diverse taxonomic classes as well as examining other factors such as 
chromosome numbers and genomic organization. 
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CONCLUSIONS 
In conclusion, the linear relationship between telomere length and physical chromosome 
arm size is consistent from individual to individual regardless of sex or age.  Variations based on 
age and gender occurs but the general trend of increasing telomere length with increasing 
chromosome arm size remains.  These data show that the distribution of telomere length 
correlates with length of chromosome arm, suggesting that the common telomere pattern in 
humans may be more dependent on chromosome arm size rather than the physical size of the 
entire chromosome. This study also has used standardized Mb measurement rather than 
photographic measurements of chromosome arm size, which eliminates the error caused by 
variable condensation of chromosomes in the metaphase spread.  
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FUTURE STUDY AND LIMITATIONS 
In general, studies of telomere length have used individuals who are the oldest and the 
youngest 5% of the population. The difference in age of the oldest and youngest individual in 
this study was only 43 years of age.  Having a greater range of ages in this study would have 
provided greater difference in telomere length which would have been more easily detected with 
the resolution of Q-FISH.  
 An interesting study would be to examine the telomere lengths of individuals who have 
large heterochromatic regions on chromosomes 1, 9, 16 or Y, which are polymorphisms.  The 
heterochromatin would increase the length of the chromosome arm and should therefore increase 
telomere length.  This type of study could also be applied to those with balanced visible 
chromosome rearrangements to see if the telomere length is affected by change in chromosome 
arm size. 
 As with most studies, it would have been beneficial to have a greater number of 
individuals in the study and a greater number of cells per individual.  Additionally, wising 
individuals in the study who were related, estimates of single chromosome arm attrition rates and 
inheritance patterns could be attempted. 
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APPENDIX A 
X/Y Probe Abbott Molecular 
 Available from http://www.abbottmolecular.com catalogue number 30-161050.  
 
ToTelVysion Probe  
 Available from www.abbottmolecular.com catalogue number 33-270000 
 
PNA Telomere Probe 
 Available from www.dako.com catalogue number K5325 
 
PNA Centromere Probe 
 Available by special request from www.dako.com  
 
Tris Buffered Saline (TBS) 
 1X concentration provided with DAKO PNA FISH probes. 
 
Phosphate Buffered Saline (PBS) 
1X concentration prepared from 10X stock solution. Available from Sigma Aldrich Cat. 
#P5493 
 
Blood culture media 
In a sterile hood mix, 500ml RPMI, 100ml FBS, 6.5ml PHA, 6.5 Pen strep, 6.5 L-
Glutamine.  Aliquot 9.0ml/tube Makes 71 tubes 
 
Colcemid 
 Available from GIBCO cat# 890-3014 
 
cDenhyb Solution 
 Available from http://www.insitus.com/DenHyb.html.  Cat#D002 
 
Carnoy’s Fixative 
 Mix a 3 to 1 ratio of cold methanol to room temperature glacial acetic acid to 
 quantity needed.  Chill to 4° C if desired.   
 
1% Formaldehyde solution 
In a coplin jar add 49ml of 1X PBS, 1.25 ml of 37% formaldehyde, and 2.5 ml of 1M 
MgCl. Store in the refrigerator at 4°C for up to 1 week.  
 
Protease/Pepsin Solution 
 In a glass coplin jar add 50 ml of distilled water, 0.025 gm of pepsin and 500 μl of 1N 
 HCl. Place jar in 37°C water bath. Prepare fresh daily.  
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2X Saline Sodium Citrate (SSC) 
Place 50 ml 20X SSC (Gibco BRL #15557-044#) into 500 ml volumetric flask.  
 Bring to 500 ml with distilled water and pH to 7.0.  
 
2X Saline Sodium Citrate 1% NP-40 
 Place 40 ml 2X SSC into a glass coplin jar.  Add 40 μl of NP- 40  
 
0.04X Saline Sodium Citrate 0.5% NP-40  
 Place 40 ml of 0.4 X SSC into a glass coplin jar and add 120 μl of NP-40  
 
PNA Telomere Probe Pretreament Solution 
Supplied in DAKO FITC PNA telomere probe kit 
 
PNA Telomere Probe Wash Solution 
Supplied in DAKO FITC PNA Telomere probe kit 
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APPENDIX B 
Table 8.  Locus and Clone ID for each FISH probe used in the ToTelVysion Kit. 
Probe Probe Size Locus/Clone ID 
1p 90 kb CEB108/T7 
1q 100 kb VIJ1 yRM21233, 1QTEL10 (D1S3738),1QTEL193 (D1S3739) 
2p 175 kb VIJ1 yRM1051 (GenBank U31389) 
2q 60 kb VIJ1 yRM2112 (D2S447), 2QTEL47 
3p 80 kb 3PTEL25 (D3S4559) 
3q 95 kb 3QTEL05 (D3S4560) 
4p 145 kb GS10K2/T7 4p  
4q 130 kb AFM A224XH1 (D4S2930) 
5p 191 kb C84C11/T3 
5q 105 kb GS3508/T7, 5QTEL703 
6p 80 kb 6PTEL48 
6q 100 kb VIJ1 yRM2158, 6QTEL543 
7p 60 kb VIJ1 yRM1185 (GenBank G31341) 
7q 95 kb VYJ1 yRM2000 (STS 2000H), 7QTEL203 
8p 135 kb AFM 197XG5 (D8S504) 
8q 100 kb VIJ1 yRM2053 
9p 115 kb 305J7-T7 
9q 95 kb VIJ1 yRM2241 (D9S325) 
10p 80 kb 10PTEL006 (GenBank:Z96139) 
10q 75 kb 10QTEL24 (D10S2490) 
11p 110 kb D11S2071 (GenBank U12896), 11PTEL033, VIJ1 yRM22093 
11q 160 kb VIJ1 yRM2072 
12p 100 kb 8M16/SP6 
12q 165 kb VIJ1 yRM2196 (Genbank 011838) 
13q 75 kb VIJ1 yRM2002 (D13S327) 
14q 160 kb sts-X583992; SHGC-361562; sts-AA0344922, 
15q 100 kb WI-5214 (D15S936) 
16p 110 kb SHGC-153362, 16PTEL032 (D16S3399) 
16q 110 kb 16QTEL013 (GenBank Z96319) 
17p 70 kb 282M15/SP6 
17q 160 kb AFMZ17yD10 (D17S928, GenBank Z23646) 
18p 160 kb VIJ1 yRM2102 (D18S552) 
18q 170 kb VIJ1 yRM2050, 18QTEL112 (D18S1390) 
19p 80 kb 129F16/SP6 
19q 160 kb D19S238E 
20p 160 kb 20PTEL18 (D20S1157) 
20q 140 kb 20QTEL14 
21q 170 kb VIJ1 yRM2029, S100B32, 21QTEL082, D21S15752 (21QTEL07) 
22q 80 kb MS607 (GenBank X58044), ACR, 22QTEL312 (D22S1726) 
Xp/Yp 175 kb DXYS129 
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